Market Cap
$94.2B
CME
CME GROUP INC.
$261.36 ▼ -1.41%
Prev close $265.10Market cap$94.2B
ConsensusHold
12-mo target$283.25 (+8.4%)
▲ Neutral
Analyst conviction 5/10
Insider Selling Cluster (2 insiders)41 New Institutional Positions9 Institutional Exits Traditional Finance
Snapshot
The big-picture read on CME right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Buy (52%)
Inst. Holders
50 funds
Inst. Value
$49.3B
Inst. Activity
41 buys / 9 sells
Insider Activity
$78.6K buy / $0.00 sell
Insider Net $
$78.6K
Social Sentiment
71° Bullish
SEC Reports
14
Congressional
2 trades
Price chart 30d -5.9%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 2, 2026 SEC
🔒 Fresh report (last 24h) — subscribers only
Sep 25, 2026 Insider
SHEPARD WILLIAM R bought 292.55 shares
Director @ $268.76 ($78.6K)
Sep 16, 2026 Insider
Tobin Jack J surrendered for taxes 51 shares
MD Chief Accounting Officer @ $272.46 ($13.9K)
Sep 16, 2026 Insider
Sprague Suzanne surrendered for taxes 308 shares
COO & Global Head of Clearing @ $272.46 ($83.9K)
Sep 14, 2026 short_volume
Short Volume: CME — 56.6% short (0.4M / 0.6M)
Short: 354,104 | Exempt: 0 | TRF Vol: 626,104 | Short Ratio: 56.6% | Off-exchange volume (dark pool
Jun 30, 2026 Inst.
JPMORGAN CHASE & CO — TRIM
5,767,731 shares ($1.3B)
Jun 30, 2026 Inst.
Jun 18, 2026 SEC NORGES BANK — NEW
4,820,646 shares ($1.1B)
Keefe, Bruyette & Woods upgrades CME to Outperform — PT $305 (flat vs prior, +20.8% upside)
ANALYST-UPGRADE — Impact 3/10
Analyst ratings buy % -5.5%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
52% rate it Buy or better · 21 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Oct 2, 2026 | Wells Fargo | INITIATE | Overweight | 54% |
| Sep 28, 2026 | TD Cowen | REITERATE | Buy | 56% |
| Sep 3, 2026 | TD Cowen | REITERATE | Buy | 56% |
| Aug 19, 2026 | Deutsche Bank | DOWNGRADE | Hold | 58% |
| Jul 23, 2026 | JP Morgan | MAINTAIN | Underweight | 55% |
| Jul 23, 2026 | B of A Securities | MAINTAIN | Underperform | 54% |
| Jul 23, 2026 | Morgan Stanley | MAINTAIN | Overweight | 55% |
| Jul 15, 2026 | Piper Sandler | MAINTAIN | Overweight | 54% |
| Jul 10, 2026 | Morgan Stanley | MAINTAIN | Overweight | 55% |
| Jul 9, 2026 | Barclays | MAINTAIN | Equal-Weight | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 9 | 7 | 3 | 0 | 52% | |
| Aug 1, 2026 | 2 | 10 | 6 | 3 | 0 | 57% | |
| Jul 1, 2026 | 2 | 10 | 6 | 3 | 0 | 57% | |
| Jun 1, 2026 | 2 | 8 | 8 | 3 | 0 | 48% | |
| May 1, 2026 | 2 | 8 | 8 | 3 | 0 | 48% | |
| Apr 1, 2026 | 2 | 8 | 7 | 3 | 0 | 50% | |
| Mar 1, 2026 | 3 | 8 | 6 | 3 | 0 | 55% | |
| Feb 1, 2026 | 3 | 8 | 6 | 3 | 0 | 55% |
Price targets
Where 16 covering analysts think CME trades over the next 12 months.
$283.25 +8.4% upside Buy
Current$261.36 Low$217.00 Median$285.50 High$330.00 16 analysts
$217.00$330.00
Analyst rating Buy· 2.5/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
71°
Bullish
BearishNeutralBullish
Recent posts
US Large Cap High-Margin Winners: Profitability Meets 2026 Market Momentum
▲ 1 · 💬 0· ⚡ 0.5
Market spent 2 years asking when does the Fed cut. Wednesday it's 85% to hike and I think everyone's watching the wrong thing.
▲ 1 · 💬 13· ⚡ 0.5
SEPT 16TH DD: The Fed gonna mess up your calls (OR) J-Pow’s successor is bringing back the 1980s. Grab your helmets? (co-written by Gemini)
▲ 1 · 💬 6· ⚡ 0.5
The 10-Year Treasury Yield Just Hit 4.81% (Highest Since Nov 2023)
▲ 1 · 💬 7· ⚡ 0.5
Warsh at Jackson Hole: Sticky 3.7% PCE pushes September rate hike odds to 58%. How are you positioning?
▲ 1 · 💬 5· ⚡ 0.5
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
14 SEC filing reports analyzed · 4 bullish, 2 bearish, 1 mixed, 7 neutral · avg impact 3.6/10.
BULLISHANALYST-UPGRADE4/10
🔒 Fresh report (last 24h) — subscribers only
Oct 2, 2026
BULLISHANALYST-UPGRADE1/10
Rothschild & Co upgrades CME to Buy — PT $323 (+22.4%)
Jun 11, 2026
BULLISHANALYST-UPGRADE3/10
Keefe, Bruyette & Woods upgrades CME to Outperform — PT $305 (flat vs prior, +20.8% upside)
Jun 18, 2026
MIXEDANALYST-DOWNGRADE4/10
Deutsche Bank downgrades CME to Hold — PT $270 (-5.9%)
Aug 19, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 14, 2026
short_volume
Short Volume: CME — 56.6% short (0.4M / 0.6M)
Short: 354,104 | Exempt: 0 | TRF Vol: 626,104 | Short Ratio: 56.6% | Off-exchange volume (dark pool + OTC)
Sep 7, 2026
dark_pool
Dark Pool: CME — 1.8M shares, 64,129 trades
Week starting 2026-09-07. Total ATS volume: 1,766,323 shares across 64,129 trades.
Aug 31, 2026
dark_pool
Dark Pool: CME — 2.4M shares, 79,853 trades
Week starting 2026-08-31. Total ATS volume: 2,449,582 shares across 79,853 trades.
Aug 28, 2026
short_volume
Short Volume: CME — 57.5% short (0.4M / 0.7M)
Short: 377,415 | Exempt: 348 | TRF Vol: 656,353 | Short Ratio: 57.5% | Off-exchange volume (dark pool + OTC)
Aug 27, 2026
short_volume
Short Volume: CME — 57.4% short (0.3M / 0.5M)
Short: 311,319 | Exempt: 28 | TRF Vol: 542,196 | Short Ratio: 57.4% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $2.92 | $2.81–$3.04 | 9.0% | -0.4% | 1↑ 2↓ | $1.7B | 14 |
| Next Q | $2.95 | $2.75–$3.07 | 6.5% | -0.3% | 0↑ 3↓ | $1.7B | 14 |
| Current FY | $12.23 | $12.00–$12.43 | 9.2% | -0.2% | 2↑ 2↓ | $7.0B | 16 |
| Next FY | $12.91 | $12.01–$13.60 | 5.6% | +0.0% | 2↑ 2↓ | $7.3B | 16 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $2.922 | — |
| 7d ago | $2.936 | -0.014 |
| 30d ago | $2.933 | -0.011 |
| 60d ago | $2.940 | -0.018 |
| 90d ago | $2.971 | -0.050 |
Institutional ownership
Which big funds own CME (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $49.3B total value (219,596,853 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, STATE. Net buying activity: 41 institutions added/increased vs 9 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 30,566,342 | $6.7B | 13.7% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 23,661,856 | $5.2B | 10.6% | — |
| STATE STREET CORP | 16,346,170 | $3.6B | 7.3% | — |
| MORGAN STANLEY | 9,728,195 | $2.1B | 4.4% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 9,271,309 | $2.0B | 4.2% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 9,167,524 | $2.0B | 4.1% | — |
| Capital World Investors | 6,822,315 | $1.5B | 3.1% | — |
| JPMORGAN CHASE & CO | 5,767,731 | $1.3B | 2.6% | TRIM -52.8% |
| Sanders Capital, LLC | 5,067,740 | $1.1B | 2.3% | — |
| NORGES BANK | 4,820,646 | $1.1B | 2.2% | NEW |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | TRIM | 12,209,761 | 5,767,731 | -52.8% | $1.3B |
| NORGES BANK | NEW | — | 4,820,646 | — | $1.1B |
| PeakShares LLC | NEW | — | 3,707 | — | $818.6M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | 2,580,320 | 3,255,443 | +26.2% | $718.9M |
| Capital Wealth Planning, LLC | ADD | 2,288,352 | 3,222,707 | +40.8% | $711.7M |
| BANK OF AMERICA CORP /DE/ | TRIM | 4,019,944 | 2,819,720 | -29.9% | $622.7M |
| MARSHALL WACE, LLP | DOUBLED | 804,218 | 2,241,304 | +178.7% | $494.9M |
| JANE STREET GROUP, LLC | DOUBLED | 336,922 | 1,815,499 | +438.8% | $400.9M |
| Qube Research & Technologies Ltd | DOUBLED | 182,778 | 1,611,307 | +781.6% | $355.8M |
| CITADEL ADVISORS LLC | DOUBLED | 373,956 | 1,505,427 | +302.6% | $332.4M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
12 insiders, 50 transactions. Net $78.6K — $78.6K bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 25, 2026 | SHEPARD WILLIAM R | Director | BUY | 292.55 | $268.76 | $78.6K |
| Sep 16, 2026 | Tobin Jack J | MD Chief Accounting Officer | TAX W/H | 51 | $272.46 | $13.9K |
| Sep 16, 2026 | Sprague Suzanne | COO & Global Head of Clearing | TAX W/H | 308 | $272.46 | $83.9K |
| Sep 16, 2026 | Sammann Derek | Sr MD Gl Hd Commodities Mkts | TAX W/H | 359 | $272.46 | $97.8K |
| Sep 16, 2026 | Vroman Ken | Chief Transformation Officer | TAX W/H | 308 | $272.46 | $83.9K |
| Sep 16, 2026 | Cutinho Sunil | Chief Information Officer | TAX W/H | 359 | $272.46 | $97.8K |
| Sep 16, 2026 | Winkler Julie | Sr MD Chief Commercial Officer | TAX W/H | 359 | $272.46 | $97.8K |
| Sep 16, 2026 | Dennis Michael G. | Global Head of Fixed Income | TAX W/H | 274 | $272.46 | $74.7K |
| Sep 16, 2026 | Fitzpatrick Lynne | President and CFO | TAX W/H | 359 | $272.46 | $97.8K |
| Sep 16, 2026 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | TAX W/H | 364 | $272.46 | $99.2K |
Congressional trades
CME trades disclosed by members of Congress, with disclosure delay.
1 members · 1 buys / 1 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Gilbert Cisneros | D | HOUSE | SELL | $1,001 - $15,000 | CME Group Inc | Jul 3, 2026(18d) |
| Jan 9, 2026 | Gilbert Cisneros | D | HOUSE | BUY | $1,001 - $15,000 | CME Group Inc | Feb 16, 2026(39d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for CME.
Shares short
5,801,564
Settlement Sep 15, 2026
Change vs prior
+3.1%
Semi-monthly cycle
Days to cover
3.3
At avg daily volume
Of shares outstanding
≈1.6%
Estimate — not % of float
All CME filing & press-release reports (14)
- ANALYST-UPGRADE reportOct 2, 2026
- Rothschild & Co upgrades CME to Buy — PT $323 (+22.4%)Jun 11, 2026
- Keefe, Bruyette & Woods upgrades CME to Outperform — PT $305 (flat vs prior, +20.8% upside)Jun 18, 2026
- Deutsche Bank downgrades CME to Hold — PT $270 (-5.9%)Aug 19, 2026
- CLUSTER reportSep 15, 2026
- 8-K reportJul 22, 2026
- 8-K reportJun 17, 2026
- DEFA14A reportMay 19, 2026
- CLUSTER reportMay 19, 2026
- COURT-RULING reportMay 14, 2026
- 8-K reportApr 22, 2026
- DEFA14A reportMar 23, 2026
- CLUSTER reportMar 23, 2026
- CLUSTER reportMar 19, 2026